Publications

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban Rationale and Design of the Hot-Pe Trial

AuthID
P-00K-MJC

Author(s)

Barco, S

Lankeit, M

Binder, H

Schellong, S

Christ, M

Beyer Westendorf, J

Empen, K

Fonseca, C

Jimenez, D

Becattini, C

Quitzau, K

Konstantinides, S

Document Type

Article

Year published

2016

Published

in THROMBOSIS AND HAEMOSTASIS, ISSN: 0340-6245

Volume: 116, Issue: 1, Pages: 191-197 (7)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1160/th16-01-0004

SCOPUS: 2-s2.0-84977474603

Wos: WOS:000379495000021

Source Identifiers

ISSN: 0340-6245

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban Rationale and Design of the Hot-Pe Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban Rationale and Design of the Hot-Pe Trial

Useful Links

Get Help